Tags:CenterDrugInvestmentLEDTechnology
Leveraging new understandings in the molecular biology of inflammation to create novel medicines that treat patients with severe inflammatory diseases.
Investors 2
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 02.03.2020 | Series A | $50M | - | techstartu... |
Mentions in press and media 7
| Date | Title | Description | Source |
| 28.09.2020 | Quench Bio is named one of Fierce Biotech's "Fierce 15&... |
CAMBRIDGE, Mass., Sept. 28, 2020 /PRNewswire/ -- Quench Bio, a company driving new insights into g... | prnewswire... |
| 27.01.2020 | Quench Bio Raises $50M in Series A Financing | Quench Bio, a Cambridge, Mass.-based company leveraging new insights into gasdermin biology and inna... | finsmes.co... |
| 27.01.2020 | Quench Bio Closes $50M Series A Financing | Quench Bio, a company leveraging new insights into gasdermin biology and innate immunology to develo... | citybizlis... |
| 27.01.2020 | Quench Bio, a biotech startup co-founded by Arix, emerges fr... | Quench Bio, a biotech startup co-founded by Arix Bioscience and Atlas Venture, has emerged from stea... | techstartu... |
| 27.01.2020 | Quench Bio emerges with $50M to treat severe inflammatory di... | Most treatments for inflammatory diseases have single targets, such as an inflammation-promoting cyt... | fiercebiot... |
| 27.01.2020 | Quench Bio Closes $50M Series A Financing |
CAMBRIDGE, MA, Quench Bio announced the completion of a $50 million Series A financing led by RA C... | vcnewsdail... |
| 27.01.2020 | Quench Bio emerges with $50M to treat severe inflammatory di... | Most treatments for inflammatory diseases have single targets, such as an inflammation-promoting cyt... | fiercebiot... |
